[{"Assets_0_FY_USD":709160000.0,"CommonStockSharesOutstanding_0_FY_shares":41389524.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-24958000.0,"NetIncomeLoss_1_FY_USD":-7455000.0,"NetIncomeLoss_4_FY_USD":-102678000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":40433171.0,"StockholdersEquity_0_FY_USD":318253000.0,"EarningsPerShareBasic_1_FY_USD":-0.18,"EarningsPerShareBasic_4_FY_USD":-2.54,"Ticker":"TVTX","CIK":"1438533","name":"RETROPHIN, INC.","OfficialName":"Travere Therapeutics Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905907401.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190226"}]